NeuroPace (NPCE) Interest & Investment Income (2021 - 2026)
NeuroPace (NPCE) posted quarterly Interest & Investment Income of $565000.0 for Q1 2026, down 28.75% year-over-year from $793000.0 in Q1 2025, and down 11.44% quarter-over-quarter from $638000.0 in Q4 2025.
NeuroPace (NPCE) Interest & Investment Income (2021 - 2026) Analysis & Trends
NeuroPace's Interest & Investment Income history runs 6 years deep, the most recent figure standing at $565000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 28.75% year-over-year to $565000.0; the TTM figure through Mar 2026 stood at $2.6 million (down 13.44% YoY), while the FY2025 annual figure was $2.8 million, down 6.88% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $565000.0, down from $638000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $827000.0 in Q1 2024, with the low at $134000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $726000.0 (2023), against an average of $649000.0.
- The sharpest annual moves came in 2023 and 2026: Interest & Investment Income soared 441.79% in 2023, then retreated 28.75% in 2026.
- NeuroPace's Interest & Investment Income stood at $800000.0 in 2022, then increased by 2.75% to $822000.0 in 2023, then fell by 17.15% to $681000.0 in 2024, then fell by 6.31% to $638000.0 in 2025, then fell by 11.44% to $565000.0 in 2026.
- Business Quant data shows NPCE's Interest & Investment Income at $565000.0 in Q1 2026, $638000.0 in Q4 2025, and $667000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | - |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn | 523,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 523,000.00 |
| Mar 31, 2026 | 565,000.00 |
| Dec 31, 2025 | 638,000.00 |
| Sep 30, 2025 | 667,000.00 |
| Jun 30, 2025 | 718,000.00 |
| Mar 31, 2025 | 793,000.00 |
| Dec 31, 2024 | 681,000.00 |
| Sep 30, 2024 | 754,000.00 |
| Jun 30, 2024 | 762,000.00 |
| Mar 31, 2024 | 827,000.00 |
| Dec 31, 2023 | 822,000.00 |
| Sep 30, 2023 | 769,000.00 |
| Jun 30, 2023 | 733,000.00 |
| Mar 31, 2023 | 726,000.00 |
| Dec 31, 2022 | 800,000.00 |
| Sep 30, 2022 | 423,000.00 |
| Jun 30, 2022 | 221,000.00 |
| Mar 31, 2022 | 134,000.00 |
| Dec 31, 2021 | 186,000.00 |
| Sep 30, 2021 | 136,000.00 |